NICE medicines guidance

The National Institute for Health and Clinical Excellence (NICE) advises the NHS regarding treatments that should be made available to patients. NICE issues this advice in several forms including Public Health Guidance that aims to prevent ill health, Clinical Guidelines which cover the treatment of individual conditions, and Technology Appraisals that describe the place in treatment of individual medicines or medical procedures.

NHS organisations commissioned by Enfield Clinical Commissioning Group (CCG) have a responsibility to ensure that treatments recommended by NICE Technology Appraisals are made available to patients. They must also review the use of any treatments that NICE recommends should not be used. Under the NHS Constitution, patients have the right to receive medicines and treatments that are recommended in NICE Technology Appraisals if their doctor thinks that these treatments are right for them. When a NICE Technology Appraisal recommends a treatment, the trust must make it available within 3 months of that recommendation.

A letter from the NHS Chief Executive, states that all NHS organisations should publish information which sets out which NICE Technology Appraisal approved medicines are included in their local formularies by 1 April 2013.

Local Trust formularies are available as below and make clear how this guidance has been implemented within the Trust:

The Enfield Medicines Management Group within Enfield CCG discusses the latest NICE guidance and Technology Appraisals and considers their impact for the CCG and local health economy. NICE guidance and Technology Appraisals that are relevant to primary care and require a change in practice are publicised to General Practitioners.  Enfield CCG does not currently operate a formulary. Enfield CCG is working with University College London Partnership and Barnet, Camden, Enfield and Haringey CCGs towards a Joint Formulary that will cover primary, secondary and tertiary care prescribing within the north central London area and will automatically include NICE Technology Appraisal recommended medicines.